Nemolizumab is a first-in-class monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31. 2 IL-31 is a neuroimmune cytokine that drives itch and is ...
MIAMI, FL / ACCESSWIRE / December 12, 2024 / Nitches Inc. (OTC PINK:NICH) is excited to announce the official placement of its first InTheZone Labs product, InTheZone Focused Extreme, on Amazon. As pa ...